What is Real-World Evidence for Clinical Trials
Real-world evidence (RWE) is clinical evidence about how a medical product performs, in terms of benefit and risk, based on analysis of real-world data (RWD). Real-world data comes from routine health care rather than a controlled trial: electronic health records, insurance claims, disease registries, and other sources. The FDA uses this same definition when deciding whether real-world evidence can support a regulatory decision, which is why the design and analysis behind it matter as much as the data itself.
Real-World Evidence for Clinical Trials
Decision Ready Real-World Evidence
EvoClinical helps sponsors generate credible, decision-ready real-world evidence using causal inference principles built for exactly this situation: when randomized trials aren’t feasible, sufficient, or timely.
We focus on clear study questions, transparent assumptions, and defensible designs, so real world evidence can support clinical, regulatory, and payer decisions with confidence.
Why Real-World Evidence and Causal Inference Matter
Regulatory Credibility
The FDA evaluates real-world evidence based on the study design, not just the data. A well-built external control arm can support a label expansion; a poorly designed one gets flagged in review and costs months.
Scientific Rigor
Real-world data that is observational is exposed to bias like confounding and immortal time bias. Skip a disciplined causal approach, and results look convincing right up until someone asks how confounding was handled.
Payer Confidence
Payers evaluate comparative effectiveness and safety data separately from regulatory approval. Evidence built on a sound causal framework holds up in that review. Evidence that can't survive scrutiny becomes a liability right when you need it most.
Which is why our approach starts with the study design, not the analysis.
Common Real-World Evidence Engagements
External Control Arms
Design and analysis comparing a single-arm trial to a real-world cohort, with transparent comparability and sensitivity analyses.
Treatment Patterns & Natural History
Description of lines of therapy, switching, adherence, and outcomes to support strategic planning.
Comparative Effectiveness Studies
Estimation of treatment effects using RWD from observational studies when randomization is not available.
Trial Design Support Using RWD and RWE
Use of real-world data to inform eligibility criteria, endpoint feasibility, and planning assumptions.
Safety & Risk Evaluation
Assessment of safety outcomes, adverse events, and treatment discontinuation in real-world practice.
Our Real-World Evidence Services
We provide end-to-end support for regulatory-grade observational studies (i.e. not a designed randomized control trial or study) using real-world data.
Study Question & Design
-Clarify the research question and causal estimand
-Translate clinical objectives into measurable exposure, comparator, outcome, and follow-up definitions
-Draft or review RWE protocols and statistical analysis plans
Data Feasibility & Fit-for-Purpose Assessment
-Assess whether available real-world data can reliably answer the question
-Identify key risks early (e.g., limited overlap, missing confounders, short follow-up)
-Recommend design or scope adjustments before protocol finalization
Cohort Design & Patient Phenotyping
-Define clinically meaningful study cohort using a target trial approach (the randomized trial the observational study is designed to approximate)
-Develop transparent rules to identify patients, exposures, outcomes, and key covariates in real-world data
-Apply inclusion and exclusion criteria that preserve interpretability and validity
Causal Study Designs
-Target trial emulation for comparative effectiveness and safety
-Active comparator, new-user designs
-Self-controlled and natural experiment designs
Confounding Control & Estimation
-Propensity score based matching, weighting, and adjustment
-Strategies for time-varying treatments and confounding
-Doubly robust approaches
-Transparent diagnostics to assess what the data can support
Robustness & Sensitivity Analyses
-Balance and overlap diagnostics
-Alternative specifications and credibility checks
-Sensitivity analyses for missing data and unmeasured confounding
-Subgroup and heterogeneity analyses with appropriate guardrails
Reporting & Stakeholder-Ready Deliverables
-Clear methods and results narratives for scientific, regulatory, and business audiences
-Tables and figures suitable for publications and review packages
-Precise, non-generic discussion of limitations
Real-World Evidence Services
Why Clients Choose EvoClinical For Real-World Evidence
Senior Causal Inference Expertise
Methodological leadership in causal inference and pharmacoepidemiology, including Dr. Tibor Schuster, Chief Scientific Advisor.
Transparent Diagnostics
We make assumptions explicit, quantify uncertainty, and test robustness rather than hiding limitations.
Target Trial Thinking
We design first and model second starting from the study you wish you could run and emulating it as closely as possible using available data.
Practical, Sponsor-Friendly Delivery
We deliver protocols, SAP language, tables, figures, and decision-ready narratives that teams can review and act on.
Talk to Our Real-World Evidence Team
FAQ - Real-World Evidence in Clinical Trials
What is real-world evidence (RWE) in clinical trials?
Real-world evidence is clinical evidence about how a medical product performs, in terms of benefit and risk, based on real-world data collected outside a randomized trial. Sources include electronic health records, insurance claims, and disease registries. The FDA uses this same definition when it decides whether real-world evidence can support a regulatory decision.
What is causal inference, and why does it matter for real-world evidence?
What's the difference between real-world data and real-world evidence?
Real-world data (RWD) is the raw information: electronic health records, claims data, and registries collected during routine care. Real-world evidence (RWE) is what results from analyzing that data to answer a specific clinical question, like whether a treatment works better than standard of care. Data alone does not answer a causal question. The analysis does.
Does the FDA accept real-world evidence in a regulatory submission?
What is an external control arm, and when do sponsors use one?
An external control arm is a comparison group built from existing data instead of a second randomized trial arm. Sponsors use one when a placebo or standard-of-care arm is not ethical or practical, often in single-arm trials for rare diseases or narrow patient populations. The comparison is only credible if the external cohort is sufficiently comparable to the trial population and key design elements.
What is target trial emulation?
Target trial emulation is a design framework for designing an observational study. You specify the exact trial you would want, its eligibility criteria, treatment strategies, and follow-up, then apply those same rules to real-world data. This reduces common biases in observational research, like immortal time bias, by forcing the same discipline a randomized trial would require.